Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Asset Writedowns and Impairment (2023 - 2024)

Historic Asset Writedowns and Impairment for Onconetix (ONCO) over the last 2 years, with Q4 2024 value amounting to -$3.2 million.

  • Onconetix's Asset Writedowns and Impairment changed N/A to -$3.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $356637.0, marking a year-over-year change of. This contributed to the annual value of $356637.0 for FY2024, which is 8981.04% down from last year.
  • Latest data reveals that Onconetix reported Asset Writedowns and Impairment of -$3.2 million as of Q4 2024.
  • In the past 5 years, Onconetix's Asset Writedowns and Impairment registered a high of $3.5 million during Q2 2023, and its lowest value of -$3.2 million during Q4 2024.